Sharekhan

Lasa Supergenerics Ltd

Thu 21/08/2025,15:59:59 NSE: LASA

₹ 9.19 -0.27 (-2.85%)
BUY NOW Buy Lasa Supergenerics Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Lasa Supergenerics Ltd

Thu 21/08/2025,16:1:0

Lasa Supergenerics Ltd

Thu 21/08/2025,15:59:59 | NSE : LASA

₹ 9.19-0.27 (-2.85%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 9.45

Previous Close

₹ 9.46

Volume

63121

Mkt Cap ( Rs. Cr)

₹46.04

High

₹ 9.86

Low

₹ 9.06

52 Week High

₹ 33.49

52 Week Low

₹ 8.42

Book Value Per Share

₹ 16.71

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Lasa Supergenerics Ltd

Your Vote -

Buy

26.92%

Hold

3.85%

Sell

69.23%

26.92%

26 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

14.07

799

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

799

Option Chain

Analyzes market sentiment, predicts Lasa Supergenerics Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Lasa Supergenerics posts Q1 net loss of Rs 21.12 cr

    13 Aug 2025, 7:40PM The company reported standalone net loss during the quarter stood at Rs 21.12 crore as compared to net loss of Rs 2.73 crore in the previous year quar

  • Lasa Supergenerics - Integrated Filing June 2025

    13 Aug 2025, 6:24PM Integrated filing June 2025

  • Lasa Supergenerics - Outcome of Board Meeting

    13 Aug 2025, 6:12PM Lasa Supergenerics Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.

  • Lasa Supergenerics - Outcome of Board Meeting

    13 Aug 2025, 5:19PM Lasa Supergenerics Limited has informed the Exchange regarding Board meeting held on August 13, 2025.

  • Lasa Supergenerics - Financial Results As On June 30, 2025

    13 Aug 2025, 5:58PM Financials results as on June 30, 2025

  • Lasa Supergenerics - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. August 13, 2025

    13 Aug 2025, 5:15PM Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Boar

  • Lasa Supergenerics - Change in Director(s)

    5 Aug 2025, 5:00PM Lasa Supergenerics Limited has informed the Exchange regarding Change in Director(s) of the company.

  • Lasa Supergenerics - Outcome of Board Meeting

    5 Aug 2025, 4:50PM Lasa Supergenerics Limited has informed the Exchange regarding Board meeting held on August 05, 2025.

  • Lasa Supergenerics - Board Meeting Intimation for The Quarter Ended June 30, 2025

    5 Aug 2025, 5:07PM Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider a

  • Lasa Supergenerics - Announcement under Regulation 30 (LODR)-Change in Management

    5 Aug 2025, 4:57PM Pursuant to reg 30 SEBI (LODR) Regulations, 2015, we wolud like ti inform you about Board of Directors Meeting held today, 05th August, 2025 at 3.00 P

  • Lasa Supergenerics - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. August 05, 2025

    5 Aug 2025, 4:47PM Pursuant to Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Di

  • Lasa Supergenerics - Resignation of Independent director

    4 Aug 2025, 4:38PM LASA SUPERGENERICS LIMITED has informed the Exchange about Resignation of Independent director.

  • Lasa Supergenerics - Resignation

    4 Aug 2025, 4:11PM Lasa Supergenerics Limited has informed the Exchange regarding Resignation of Ms Mr. Ajay Sukhwani and Ms Ekta Gurnasinghani as Non- Executive Indepen

  • Lasa Supergenerics - Announcement under Regulation 30 (LODR)-Resignation of Director

    4 Aug 2025, 3:57PM With the reference to above and in compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby inform you that Mr. Ajay Sukhwani and Ms

  • Lasa Supergenerics - Shareholders meeting

    1 Aug 2025, 5:23PM Lasa Supergenerics Limited has informed the Exchange regarding Notice of Postal Ballot

  • Lasa Supergenerics - Notice Of Postal Ballot, Seeking Shareholders' Approval For Appointment Of Mr. Prathamesh Chalke As Exec

    1 Aug 2025, 5:13PM Pursuant to Reg 30 SEBI (LODR) regulation, 2015 we enclose herewith postal ballot Notice , seeking approval of Members of the Company for below mentio

  • Lasa Supergenerics - Resignation of Independent director

    1 Aug 2025, 1:42PM LASA SUPERGENERICS LIMITED has informed the Exchange about Resignation of Independent director.

  • Lasa Supergenerics - Resignation

    1 Aug 2025, 1:30PM Lasa Supergenerics Limited has informed the Exchange regarding Resignation of Ms Manali Bhagtani as Non- Executive Independent Director of the compan

  • Lasa Supergenerics - Announcement under Regulation 30 (LODR)-Resignation of Director

    1 Aug 2025, 1:26PM With the reference to disclosure submitted on dated 31.07.2025, we hereby submit the revised Disclosure.

  • Lasa Supergenerics - Resignation

    1 Aug 2025, 1:23PM Lasa Supergenerics Limited has informed the Exchange regarding Resignation of Mr Mr. Hardesh Tolani as Non- Executive Independent Director of the comp

  • Lasa Supergenerics - Announcement under Regulation 30 (LODR)-Resignation of Director

    1 Aug 2025, 1:18PM With the reference to the above anf compliance with Reg 30 of SEBI (LODR) Regulations 2015, We hereby inform you that Mr. Hardesh Tolani , independent

  • Lasa Supergenerics - Resignation of Independent director

    31 Jul 2025, 4:33PM LASA SUPERGENERICS LIMITED has informed the Exchange about Resignation of Independent director.

  • Lasa Supergenerics - Resignation

    31 Jul 2025, 4:15PM Lasa Supergenerics Limited has informed the Exchange regarding Resignation of Mr Ms. Manali Bhagtani, Independent Director as Non- Executive Independe

  • Lasa Supergenerics - Announcement under Regulation 30 (LODR)-Resignation of Director

    31 Jul 2025, 4:03PM With the reference compliance with Reg 30 of SEBI (LODR) Regulations 2015, We hereby inform that Ms Manali Bhagtani has tendered her resignation as In

  • Lasa Supergenerics has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    22 Jul 2025, 7:04AM As of June 2025, 53.65% is owned by Indian Promoters and 46.35% by Public. <p align=justify> Top Promoter holding highest number of shares of Lasa Sup

  • Lasa Supergenerics - General Updates

    18 Jul 2025, 4:23PM Lasa Supergenerics Limited has informed the Exchange about General Updates

  • Lasa Supergenerics - Announcement Under Regulation 30 SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015

    18 Jul 2025, 4:13PM Futher update on Factory Operations Post fire Incident

  • Lasa Supergenerics - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    16 Jul 2025, 5:23PM Lasa Supergenerics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Lasa Supergenerics - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    16 Jul 2025, 5:12PM Please find enclosed herewith certifcate under 74 (5) of SEBI ( Depositories and Participants) Regulations, 2018 for quarter ended June, 30 2025 rec

  • Lasa Supergenerics - Trading Window-XBRL

    30 Jun 2025, 3:45PM LASA SUPERGENERICS LIMITED has informed the Exchange about Closure of Trading Window

  • Lasa Supergenerics - Trading Window

    30 Jun 2025, 3:37PM Lasa Supergenerics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulation

  • Lasa Supergenerics - General Updates

    24 Jun 2025, 1:20PM Lasa Supergenerics Limited has informed the Exchange about General Updates

  • Lasa Supergenerics - Updates On Restart Of Manufacturing Operations

    24 Jun 2025, 1:13PM With reference to our earlier disclosure dated 19th May, 2025, regarding fire indident at our manufacturing unit and pursuant to Regulation 30 of SEBI

  • Lasa Supergenerics - General Updates

    3 Jun 2025, 4:18PM Lasa Supergenerics Limited has informed the Exchange about General Updates

  • Lasa Supergenerics - Related Party Transactions

    28 May 2025, 5:58PM Lasa Supergenerics Limited has informed the Exchange about related Party Transactions

  • Lasa Supergenerics - Outcome of Board Meeting

    28 May 2025, 5:33PM Lasa Supergenerics Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.

  • Lasa Supergenerics - Integrated Filing- Financial

    28 May 2025, 5:19PM Integrated Filing

  • Lasa Supergenerics - Outcome of Board Meeting

    28 May 2025, 4:16PM Lasa Supergenerics Limited has informed the Exchange regarding Board meeting held on May 28, 2025.

  • Lasa Supergenerics - Related Party Transaction For The Quarter And The Year Ended March 31, 2025

    28 May 2025, 5:57PM Related party transaction for the quarter and year ended March 31, 2025

  • Lasa Supergenerics posts Q4 net loss of Rs 14.29 cr

    28 May 2025, 5:23PM The company reported standalone net loss during the quarter stood at Rs 14.29 crore as compared to net loss of Rs 15.30 crore in the previous year qua

  • Lasa Supergenerics - Integrated Filing (Financial)

    28 May 2025, 5:08PM Integrated filing (Financials) for the Quarter and the year ended 31st March, 2025

  • Lasa Supergenerics - Board Meeting Outcome for Outcome Of Board Meeting

    28 May 2025, 4:14PM Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Boar

  • Lasa Supergenerics - General Updates

    26 May 2025, 9:49PM Lasa Supergenerics Limited has informed the Exchange about General Updates

  • Lasa Supergenerics to start trial runs from Nov 25

    23 Nov 2017 , 12:13PM Lasa Supergenerics announces that it will start its pilot production trial runs at its Unit IV from November 25, 2017
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Lasa Supergenerics Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 96.6762 118.2859 148.6341 158.9171 175.9458
Liabilities 96.6762 118.2859 148.6341 158.9171 175.9458
Equity 50.1012 50.1012 40.6727 40.6727 40.6727
Gross Profit 2.1658 -6.5935 15.6327 47.221 29.948
Net Profit -21.7306 -38.6207 -5.3672 22.7777 3.6284
Cash From Operating Activities 2.1387 -17.3004 10.4898 41.3103 13.6224
NPM(%) -20.82 -29.8 -3.91 11.25 2.16
Revenue 104.335 129.5678 137.1267 202.3795 167.2712
Expenses 102.1692 136.1613 121.494 155.1585 137.3232
ROE(%) -25.95 -46.13 -6.41 27.2 4.33

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
16 Sep 2022 0.25 2.5 0 62.35
15 Sep 2021 0.25 2.5 0 73.6

Peers

Other companies within the same industry or sector that are comparable to Lasa Supergenerics Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sharda Cropchem Ltd 968.40 1.74 20.81 84.09 337.37 0.93
Amines and Plasticizers Ltd 226.09 -1.78 31.27 51.28 372.61 0.22
Indogulf Cropsciences Ltd 109.20 -1.79 0.00 21.92 49.78 0.00
Grauer and Weil (India) Ltd 115.60 0.00 34.92 422.58 346.70 0.43

Company Info

Lasa Supergenerics Limited was incorporated as a public limited company on March 11, 2016 (Company Registration Number: 274202 and having Corporate Identification Number: U24233MH2016PLC274202) under the Companies Act, 2013 with the Registrar of Companies, Maharashtra ("RoC") 2021 -LASA launched new product Oxyclozanide Creating new Capacity as a brown field expansion issued by the company.

Lasa Supergenerics Limited was incorporated as a public limited company on March 11, 2016 (Company Registration Number: 274202 and having Corporate Identification Number: U24233MH2016PLC274202) under the Companies Act, 2013 with the Registrar of Companies, Maharashtra ("RoC") 2021 -LASA launched new product Oxyclozanide Creating new Capacity as a brown field expansion issued by the company.

Read More

Parent Organisation

Lasa Supergenerics Ltd.

Founded

11/11/2016

Managing Director

Dr.Omkar Pravin Herlekar

NSE Symbol

LASABE

FAQ

The current price of Lasa Supergenerics Ltd is ₹ 9.19.

The 52-week high for Lasa Supergenerics Ltd is ₹ 9.86 and the 52-week low is ₹ 9.06.

The market capitalization of Lasa Supergenerics Ltd is currently ₹ 46.04. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Lasa Supergenerics Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Lasa Supergenerics Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Lasa Supergenerics Ltd shares.

The CEO of Lasa Supergenerics Ltd is Dr.Omkar Pravin Herlekar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT